Gastroprotective effects of piper carpunya against diclofenac-induced gastric lesions in rats

Pharmaceutical Biology

Volumn 46, Issue 12, 2008, Pages 829-837

  Trabadela, C ^a   Sanchez Fidalgo S ^a   Mino P ^b   Berenguer, B ^a   Quilez, A ^a   De La Puerta, R ^a   Martin M J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

Author keywords

Anti inflammatory drugs; gastroprotection; oxidative stress; Piper carpunya

Indexed keywords

EID: 77951206296     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802366686     Document Type: Article

References (35)

1. Aizen E, Kagan G, Assy B, Iobel R, Bershadsky Y, Gilhar A (2005): Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia. Isr Med Assoc J 7: 78-81. (Pubitemid 40260062)
2. Alarcon de la Lastra C, Martin MJ, La Casa C, Motilva V (1994): Antiulcerogenicity of the flavonoid fraction from Bidens aurea: Comparison with ranitidine and omeprazole. J Ethnopharmacol 42: 161-168. (Pubitemid 24177361)
3. Bafna PA, BalaramanR(2004):Anti-ulcer and antioxidant activity of DHC-1, a herbal formulation. J Ethnopharmacol 90: 123-127. (Pubitemid 38091696)
4. Bandyopadhyay U, Biswas K, Sengupta A, Moitra P, Dutta P, Sarkar D, Debnath P, Ganguly CK, Banerjee RK (2004): Clinical studies on the effect of Neem (Azadirachta indica) bark extract on gastric secretion and gastroduodenal ulcer. Life Sci 75: 2867-2878. (Pubitemid 39349253)
5. Basten J (1981): Las plantas medicinales de los Kallawasyas. La Paz, Proyecto Concern Bolivia, p.145.
6. Berenguer B, Sánchez LM, Quilez A, López-Barreiro M, de Haro O, Gálvez J, Martín MJ (2006): Protective and antioxidant properties of Rhizophora mangle L. against NSAID-induced gastric ulcers. J Ethnopharmacol 113: 194-200. (Pubitemid 41796917)
7. Bjordal JM, Ljunggren AE, Klovning A, Slordal L (2004): Non-steroidal anti-inflammatory drugs, including cyclooxygenase-2 inhibitors, in osteoarthritic knee pain: Metaanalysis of randomised placebo controlled trials. BMJ 329: 1317.
8. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982): Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209. (Pubitemid 12171880)
9. Bredie SJ, Wollersheim H, Verheugt FW, Thien T (2003): Lowdose aspirin for primary prevention of cardiovascular disease. Semin Vasc Med 3: 177-184.
10. Carden DL, Granger DN (2000). Pathophysiology of ischemiareperfusion injury. J Pathol 190: 255-266.
11. de las Heras B, SlowingK, Benedi J, Carretero E, Ortega T, Toledo C, Bermejo P, Iglesia SI, Abad MJ, Gomez-Serranillos P, Liso PA, Villar A, Chiriboga X (1998): Anti-inflammatory and antioxidant activity of plants used in traditionalmedicine in Ecuador. J Ethnopharmacol 61: 161-166. (Pubitemid 28297906)
12. Grisham MB, Beniot JN, Granger DN (1990): Assessment of leukocyte in involvement during ischemia and reperfusion of intestine. Methods Enzymol 186: 729-742. (Pubitemid 20280020)
13. Grover JK, Yadav SP (2004). Pharmacological actions and potential uses of Momordica charantia: A review. J Ethnopharmacol 93: 123-132. (Pubitemid 38739282)
14. Guerrero RO, Rivera SM, Rivera S, Sueiro LA (2003): Bioassay screening of Amazonian plants. PR Health Sci J 22: 291-297.
15. Gupta MP (1995): 270 Plantas Medicinales Iberoamericanas. Colombia, Convenio Andres Bello, Santa Fé de Bogotá: pp. 112, 126, 162.
16. GyiresK(2005):Gastric mucosal protection: From prostaglandins to gene-therapy. Curr Med Chem 12: 203-215. (Pubitemid 40089834)
17. Halliwell B (1995): Antioxidant characterization: Methodology and mechanism. Biochem Pharmacol 49: 1341-1348.
18. Hawkey CJ (2000): Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119: 521-535. (Pubitemid 30622003)
19. Jiménez D, Martín MJ, Alarcon de la Lastra C, Bruseghini L, Esteras A, Herrerías JM, Motilva V (2004): Role of L-arginine in ibuprofen-induced oxidative stressand neutrophil infiltration in gastric mucosa. Free Radic Res 38: 903-911. (Pubitemid 39341685)
20. Kettle AJ, Gedye CA, Winterbourn CC (1997): Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrochloride. Biochem J 21: 503-508. (Pubitemid 27056501)
21. Lans C, Brown G (1998): Observations on ethnoveterinary medicines in Trinidad and Tobago. Prev Vet Med 35: 125-142. (Pubitemid 128430957)
22. Lefkowitz DL, Gelderman MP, Fuhrmann SR, Graham S, Starnes JD, Lefkowitz SS, Bollen A, Moguilevsky N (1999): Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis. Clin Immunol 91: 145-155. (Pubitemid 29203413)
23. Martin M, La Casa C, Motilva V, Lopez A, Alarcon de la Lastra C (1996): Healing process induced by a flavonic fraction of Bidens aurea on chronic gastric lesion in rat. Role of angiogenesis and neutrophil inhibition. Z Naturforsch 51: 570-577. (Pubitemid 26350961)
24. McCord CP, Fridovich I (1969): Superoxide dismutase. J Biol Chem 244: 6049-6055.
25. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoults JRS (1988): Selectivity of neutrophil 5-lipooxigenase and cyclooxygenase inhibition by an anti-inflammatory flavonoid glycosyde and related aglycone flavonoids. J Pharm Pharmacol 40: 787-792.
26. Nakatani N, Inatani R, Ohta H, Nishioka A (1986): Chemical constituents of peppers (Piper spp.) and application to food preservation: naturally occurring antioxidative compounds. Environ Health Perspect 67: 135-142. (Pubitemid 16041381)
27. Ohkawa H, Ohishi N, Yagi K (1979): Assay for lipid peroxide for animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358. (Pubitemid 9194347)
28. Sakamoto C (2003): NSAIDs caused gastric mucosal injury:With a special reference to COX-2. J Nippon Med Sch 70: 5-11. (Pubitemid 36305745)
29. Sánchez S, Martín MJ, Ortiz P, Motilva V, Alarcón de la Lastra C (2002): Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa. Comparison with acetaminophen and diclofenac. Dig Dis Sci 47: 1389-1398. (Pubitemid 34606645)
30. Sullivan W, Sarembock IJ, Linden J (2000): The role of inflammation in vascular diseases. J Leukoc Biol 67: 591-602.
31. Tapia A, Rodriguez J, Theoduloz C, Lopez S, Feresin GE, Schmeda-Hirschmann G (2004): Free radical scavengers and antioxidants from Baccharis grisebachii. J Ethnopharmacol 95: 155-161. (Pubitemid 39422663)
32. Villegas I, La Casa C, Alarcón de la Lastra C, Motilva V, Herrerias JM, Martín MJ (2004): Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: Role of prostaglandins and inflammatory response. Life Sci 74: 873-884. (Pubitemid 37501136)
33. Wang HM, Zhang GY (2005): Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo. World J Gastroenterol 11: 340-343.
34. Yoshikawa T, Naito Y, Kishi A, Kaneko T, Linuma S, Ichikawa H, Yasuda M, Takahashi S, Kondo M (1993): Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 34: 732-737. (Pubitemid 23185094)
35. Zimmerman BJ, Granger DN (1992): Reperfusion injury. Surg Clin North Am 72: 65-83.